Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Dr. Jolien Robijns
About This Webinar
Retrospective evaluation of the safety of photobiomodulation therapy in patients with breast cancer: preliminary results
Who can view: People who attended or registered for the webinar only
Webinar Price: Free
Featured Presenters
Jolien Robijns obtained her master’s degree in Biomedical Sciences at Hasselt University, Belgium, in 2014. In October 2018, she graduated as a Doctor in Biomedical Sciences at Hasselt University under Prof. Dr. Jeroen Mebis, Head of the Medical Oncology department (Jessa Hospital, Hasselt, BE). Her research focuses on the use of photobiomodulation (PBM) in supportive cancer care. The main topic of her Ph.D. project was the application of PBM for the prevention and management of acute radiodermatitis in cancer patients. She now further investigates the beneficial effects of PBMT in an oncologic setting for other indications as a postdoctoral researcher. Since November 2019, the research group under Prof. Mebis has set up the Limburg Oncologic Laser Institute (LOwLIght). Jolien presented her research at several (inter)national conferences in the field of oncology and PBM. She received several prizes for her research, which has gained attention in the Belgian media. Dr. Robijns is also a member of the Belgian Laser Group, WALT, ASLMS, and MASCC.
Conversation
3:12 PM - Tuesday - October 5, 2021
Dear Dr Robijns,
Excellet confference.... thanks a lot for sharing your work. I believe is of a great help for patients undergoing RT and suffering its side effects. Since this study was disigned some years ago, I wander if you have already treated the tipe of patients that were excluded in this study (mastectomy, breast implant, second RT, etc). From your experience, would be of a risk to use PBM on them? Again, thank you for sharing
Excellet confference.... thanks a lot for sharing your work. I believe is of a great help for patients undergoing RT and suffering its side effects. Since this study was disigned some years ago, I wander if you have already treated the tipe of patients that were excluded in this study (mastectomy, breast implant, second RT, etc). From your experience, would be of a risk to use PBM on them? Again, thank you for sharing
1:54 PM - Sunday - October 3, 2021
Excellent talk Dear Jolien +++! RJ@
Attended
(63)
Recommended